Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset

Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset

Abstract Introduction We assessed the risk factors and outcome of COVID-19 in patients with autoimmune rheumatic diseases(AIRD) who contracted infection while on background treatment with tofacitinib. Methods This is a non-interventional, cross-sectional, questionnaire based telephonic study which i...

Full description

Bibliographic Details
Main Authors: Pramod Chebbi, Vineeta Shobha, Vijay K Rao, Vikram Haridas, Ramya Janardana, Benzeeta Pinto, Sharath Kumar, Abhishek Patil, Roopa Tekkatte, Manasa Salanke, K M Mahendranath
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Rheumatology
Subjects:
Autoimmune rheumatic diseases
SARS-CoV-2 infection
Covid-19
Concomitant tofacitinib treatment
Online Access:https://doi.org/10.1186/s41927-023-00345-8

Internet

https://doi.org/10.1186/s41927-023-00345-8

Similar Items